NCT06300502View on ClinicalTrials.gov

Assessing the Efficacy of Repeat, Monthly Treatments of Cutaneous Neurofibromas (cNFs)

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

June 30, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Neurofibromas, CutaneousNeurofibromatosis 1
Interventions
DRUG

Kybella

Injection into the cutaneous Neurofibromas lesion.

DRUG

Asclera

Injection into the cutaneous Neurofibromas lesion.

DEVICE

755nm Alexandrite Laser

Pulse laser at a wavelength of 755nm to the cutaneous Neurofibromas lesion.

DEVICE

1064nm Nd:YAG Laser

Pulse laser at a wavelength of 1064nm to the cutaneous Neurofibromas lesion

Trial Locations (1)

02114

Wellman Center for Photomedicine, Boston

All Listed Sponsors
collaborator

Johns Hopkins University

OTHER

lead

Massachusetts General Hospital

OTHER

NCT06300502 - Assessing the Efficacy of Repeat, Monthly Treatments of Cutaneous Neurofibromas (cNFs) | Biotech Hunter | Biotech Hunter